Point72 Asset Management’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27M Buy
399,392
+248,029
+164% +$14.1M 0.05% 660
2025
Q4
$6.28M Sell
151,363
-1,372,046
-90% -$56.8M 0.01% 1671
2025
Q3
$61.4M Buy
1,523,409
+48,116
+3% +$1.4M 0.13% 222
2025
Q2
$38.4M Sell
1,475,293
-191,881
-12% -$4.62M 0.09% 305
2025
Q1
$40.8M Buy
1,667,174
+1,358,915
+441% +$38.2M 0.11% 254
2024
Q4
$8.84M Sell
308,259
-437,804
-59% -$15M 0.02% 736
2024
Q3
$28.1M Buy
746,063
+635,653
+576% +$22.3M 0.1% 321
2024
Q2
$3.49M Sell
110,410
-75,827
-41% -$2.63M 0.01% 944
2024
Q1
$8.18M Buy
+186,237
New +$7.61M 0.02% 789

Other funds holding CGON